🇪🇺 Erbitux in European Union

EMA authorised Erbitux on 29 June 2004

Marketing authorisation

EMA — authorised 29 June 2004

  • Status: approved

Erbitux in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Erbitux approved in European Union?

Yes. EMA authorised it on 29 June 2004.

Who is the marketing authorisation holder for Erbitux in European Union?

Imclone is the originator. The local marketing authorisation holder may differ — check the official source linked above.